Evidence map›Paper›PMID 33402821›Full record

ArticleInternational journal of nanomedicine2020

Improved in vitro and in vivo Anti-

Luciani Gaspar de Toledo, Matheus Aparecido Dos Santos Ramos, Patrícia Bento da Silva, Camila Fernanda Rodero, Veridiana de Sá Gomes, Anderson Noronha da Silva, Fernando Rogério Pavan, Isabel Cristiane da Silva, Fernando Bombarda Oda, Danilo Luis Flumignan and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Deleterious Effects ofInsects · 2023
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Luciani Gaspar de ToledoSchool of Pharmaceutical Sciences, Department of Biological Sciences, São Paulo State University (UNESP), São Paulo, Brazil.ORCID 0000-0001-6276-0150
Matheus Aparecido Dos Santos RamosSchool of Pharmaceutical Sciences, Department of Biological Sciences, São Paulo State University (UNESP), São Paulo, Brazil.
Patrícia Bento da SilvaDepartment of Genetics and Morphology, University of Brasília (UnB), Institute of Biological Sciences, Brasília, Distrito Federal, Brazil.
Camila Fernanda RoderoSchool of Pharmaceutical Sciences, Department of Drug and Medicines, São Paulo State University (UNESP), São Paulo, Brazil.
Veridiana de Sá GomesSchool of Pharmaceutical Sciences, Department of Biological Sciences, São Paulo State University (UNESP), São Paulo, Brazil.
Anderson Noronha da SilvaSchool of Pharmaceutical Sciences, Department of Biological Sciences, São Paulo State University (UNESP), São Paulo, Brazil.
Fernando Rogério PavanSchool of Pharmaceutical Sciences, Department of Biological Sciences, São Paulo State University (UNESP), São Paulo, Brazil.
Isabel Cristiane da SilvaSchool of Pharmaceutical Sciences, Department of Biological Sciences, São Paulo State University (UNESP), São Paulo, Brazil.ORCID 0000-0001-9617-9858
Fernando Bombarda OdaSchool of Pharmaceutical Sciences, Department of Natural Active Principles and Toxicology, São Paulo State University (UNESP), São Paulo, Brazil.ORCID 0000-0001-7217-0840
Danilo Luis FlumignanSão Paulo Federal Institute of Education, Science and Technology (IFSP), São Paulo, Brazil.ORCID 0000-0003-3207-4891
André Gonzaga Dos SantosSchool of Pharmaceutical Sciences, Department of Natural Active Principles and Toxicology, São Paulo State University (UNESP), São Paulo, Brazil.
Marlus ChorilliSchool of Pharmaceutical Sciences, Department of Drug and Medicines, São Paulo State University (UNESP), São Paulo, Brazil.
Margarete Teresa Gottardo de AlmeidaFaculty of Medicine of São José do Rio Preto (FAMERP), Department of Infectious Diseases, São José do Rio Preto, São Paulo, Brazil.
Taís Maria BauabSchool of Pharmaceutical Sciences, Department of Biological Sciences, São Paulo State University (UNESP), São Paulo, Brazil.
Universidade Estadual Paulista (Unesp) · BRFaculdade de Medicina de São José do Rio Preto · BRFederal Institute of São Paulo · BRUniversidade de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeVulvovaginal candidiasis (VVC) is an opportunistic fungal infection that adversely affects a woman's health, due to unpleasant symptoms, therapeutic challenges, and the emergence of resistant strains. The association of natural products and nanotechnology is important to improve the antifungal potential of medicinal plants. We aimed to evaluate the in vitro and in vivo anti-

methodsThe chemical analysis of the EO was performed by gas chromatography-mass spectrometry. The ME and ME+EO were characterized by scattering, zeta potential, polarized light microscopy, rheological assays, mucoadhesiveness and transmission electronic microscopy. The in vitro antifungal activity of the EO and ME+EO were evaluated by microdilution technique. The toxicity of EO and ME+EO was analyzed on human cell line HaCat and using alternative model assay with

resultsThe main compounds of the EO were found to be citronellal, geranial, geraniol, citronellol, and neral. The formulations exhibited suitable size, homogeneity, negative charge, isotropic behavior, highly organized structure, and pseudoplastic behavior, for vaginal application. TEM photomicrographs showed possible EO droplets inside the spherical structures. The EO, when loaded into the ME, exhibited an improvement in its antifungal action against

conclusionThe EO and ME+EO are promising alternatives for the control of fungal infections caused by

Indexed as

Amphotericin BAnimalsAntifungal AgentsArtemiaCandida albicansCymbopogonEmulsionsErgosterolFemaleHaCaT CellsHumansInhibitory Concentration 50Mice, Inbred C57BLMicrobial Sensitivity TestsOils, VolatileParticle SizeAmphotericin BAntifungal AgentsEmulsionsErgosterolOils, Volatilecitronellananostructured lipid systemtherapeutic treatmentvulvovaginal candidiasis

Identifiers

PMID33402821
PMCPMC7778679
OpenAlexW3115745245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.